Results 151 to 160 of about 4,784 (224)

Correction to: Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase). [PDF]

Hum Reprod Open
europepmc   +1 more source

Comparison of oral dydrogesterone and vaginal progesterone for luteal phase support in natural and modified natural cycle frozen embryo transfers. [PDF]

J Ovarian Res
Xie YX, Jiang LL, Huang J, Li L, Qiu Q, Pan P, Li Y.   +6 more
europepmc   +1 more source

Intensive luteal phase support in hormone replacement and modified natural cycle frozen embryo transfers in ovulatory patients: A propensity score-matched study. [PDF]

PLoS One
Nguyen HTL, Le TD, Hoang LB, Phi ATT, Nguyen HP, Luu QQ, Tran TT, Nguyen TTT, Nguyen HT, Giap PTM, Nguyen TL, Cao AT, Hoang HQ, Nguyen HT, Do TV, Hugues JN, Le H.   +16 more
europepmc   +1 more source

Sequential therapy for infertility in women with polycystic ovary syndrome and luteal phase defects by Yangxin Dianji decoction and Nuangong Tiaojing decoction: a real-world study. [PDF]

J Tradit Chin Med
Xiaoyue J, Yinyin D, Xinyuan L, Fang R, Yeting Z, Yanli H, Huifang Z.   +6 more
europepmc   +1 more source

Serum estradiol (E2), progesterone (P), and human chorionic gonadotropin (HCG), D-dimer (D-D) fibrinogen (FIB) levels after low molecular weight heparin sodium on preventing miscarriage in patients with adverse pregnancy and delivery. [PDF]

J Med Biochem
Pei L, Wang T, Yang Q.
europepmc   +1 more source

P450 engineering via structure-guided rational design achieves high C21-selectivity and bioconversion in steroid biosynthesis. [PDF]

Synth Syst Biotechnol
Yang J, Li R, Gao Q, Ma L, Wang Q, Ma G, Fan Y, Li S, Xu LH.   +8 more
europepmc   +1 more source

RETRACTION: <b>Comparison of the Effect of Dydrogesterone and Natural Micronized Progesterone for Luteal-Phase Support in Assisted Reproductive Technology Cycles: A Single-Blind Randomized Clinical Trial Study</b>. [PDF]

Health Sci Rep
europepmc   +1 more source

Cumulative Live Birth Rates in Women Undergoing Progestin-Primed Ovarian Stimulation Using Medroxyprogesterone Acetate, Dydrogesterone, and Progesterone: A Retrospective Analysis. [PDF]

Drug Des Devel Ther
Wu F, Lin J, Zhang J, Wang X, Huang J, Lin J.   +5 more
europepmc   +1 more source

Unmasking the risk: clinical trials versus real-world evidence on dydrogesterone and birth defects. [PDF]

Hum Reprod Open
Parazzini F, Cantarutti A, Esposito G.
europepmc   +1 more source

Pregnancy Rate Is High When the Length of the Luteal Phase During the In Vitro Fertilization Hormone Replacement Cycle Is 144 Hours or More Before Embryo Transfer. [PDF]

Cureus
Nishio E, Oikawa S, Sakakibara E, Ishikawa M, Kotani K, Yoshizawa H, Miyamura H, Hayashi T, Nishizawa H.   +8 more
europepmc   +1 more source